GSK first of big pharma to respond to "patent box" proposals
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline has responded to UK Chancellor of the Exchequer Alistair Darling's plans for a "patent box" by announcing it is to invest around £500 million in UK manufacturing.